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CAML Is Required for Efficient
EGF Receptor Recycling
before they are targeted to subsequent trafficking desti-
nations (Flint et al., 1997; Haj et al., 2002). Recent work
has implicated c-Cbl, an E3 ubiquitin ligase, in the down-
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Although many studies suggest that endocytosed re-3 Department of Genetics
St. Jude Children’s Research Hospital ceptors that are not ubiquitinated are recycled to the
plasma membrane from both early and recycling endo-Memphis, Tennessee 38105
somes (Levkowitz et al., 1998; Bao et al., 2000; Seto et
al., 2002), little is known about the factors that select
and sort cargo into the recycling pathway. IncreasedSummary
sorting of receptors into the recycling endosome can
significantly enhance the long-term mitogenic effects ofCalcium-modulating cyclophilin ligand (CAML) is a
ubiquitous protein that has been implicated in signal- growth factors by increasing the availability of surface
receptors (Fallon et al., 2000; Sarkar et al., 2002), thusing from the cell surface receptor TACI in lymphocytes,
although its role and mechanism of action are un- introducing an additional level of signal regulation.
v-Cbl, a viral dominant-negative form of c-Cbl, wasknown. To study its function in the mouse, we dis-
rupted the CAML gene and found it to be required shown to exert its oncogenic effects partly by blocking
c-Cbl action and shunting internalized EGFR back tofor early embryonic development, but not for cellular
viability. CAML-deficient cells have severely impaired the cell surface (Levkowitz et al., 1998).
CAML is a ubiquitous protein of 296 amino acids. Itproliferative responses to the epidermal growth factor
(EGF). Although EGF-induced activation of signaling contains three putative transmembrane domains near
its C terminus and has been shown to be a residentintermediates and internalization of the EGF receptor
(EGFR) are normal in the absence of CAML, the recycling protein of the endoplasmic reticulum (Bram and Crab-
tree, 1994; Holloway and Bram, 1998). CAML was pre-of internalized receptors to the plasma membrane is
defective, leading to its reduced surface accumulation. viously identified as an intracellular binding partner for
the lymphocyte-specific tumor necrosis factor receptorWe demonstrate that CAML normally associates di-
rectly with the kinase domain of the EGFR in a ligand- family member TACI (von Bulow and Bram, 1997). Al-
though it was postulated to participate in signaling prop-dependent manner. These data implicate CAML in
EGFR signaling and suggest that it may play a role in erties of the receptor, CAML bears no homology to
known proteins (Bram and Crabtree, 1994), and itsreceptor recycling during long-term proliferative re-
sponses to EGF. mechanism of action and physiological significance re-
main unknown. Our data presented in this study impli-
cate CAML in EGFR signaling and suggest that it mayIntroduction
play a role in receptor recycling during long-term prolif-
erative responses to EGF.Traditionally, signal transduction and receptor traffick-
ing were thought to be unrelated cellular processes.
Recent advances in these fields, however, suggest that Results
they are highly interdependent (for reviews, see DiFiore
and Camilli, 2001; Seto et al., 2002). Cellular responses CAML Knockout Results in Embryonic Lethality,
to signaling events depend on the nature of second While It Is Not Required for Cellular Viability
messengers as well as the timing, duration, and location To elucidate the critical physiological role of CAML in
of activation (Vieira et al., 1996; Madhani, 2001; Seto et vivo, we generated knockout mice by homologous re-
al., 2002). Receptor tyrosine kinases (RTKs) such as the combination (Figures 1A and 1B). Analyses of F1 genera-
EGFR undergo rapid endocytosis after ligand binding tion crosses showed that homozygous loss of CAML
(Ceresa and Schmid, 2000). Internalized receptors con- resulted in embryonic lethality. Of 207 live mice born to
tinue to activate efficiently a subset of signaling targets pairings of CAML heterozygotes, 73 were CAML/, 134
localized to the early endosome (DiGuglielmo et al., CAML/, and 0 CAML/, yielding a statistical distribu-
1994; Haugh et al., 1999) and eventually enter a complex tion of 1:1.8:0 for the wild-type, heterozygous, and ho-
endosomal sorting process. Hyperphosphorylated re- mozygous mutant genotypes, respectively. To assess
ceptors migrate to the ER to be dephosphorylated by the when CAML/ embryos die, we collected embryos from
ER-resident protein tyrosine phosphatase 1B (PTP1B) heterozygous intercrosses at various stages of develop-
ment and genotyped them by a nested PCR assay. Dis-
section and screening of embryos at days ranging from*Correspondence: bramr@mayo.edu
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Figure 1. Generating CAML Knockout Mice
and Cells
(A) Diagram of the CAML locus, targeting
plasmid, and probes (labeled 1 and 2) used
to detect homologous recombination. Black
boxes and Roman numbers denote exons. K,
Kpn1; N, Nde1.
(B) A Southern blot of Nde1-digested tail DNA
from offspring of a heterozygous cross using
probe 2.
(C) Immunobloting of lysates from retinoic
acid-differentiated CAML/ and CAML/
ERV cell pools (designated CAML-negative
cells; ERV: empty mouse embryonic retrovi-
rus), three CAML-reconstituted cell pools
(designated CAML-positive cells), and indi-
cated human and mouse cell lines using anti-
CAML polyclonal antibodies (top). Coomas-
sie staining of the same Western membrane
showed equal loading of lysates (bottom).
(D) Phase micrographs of differentiated
CAML-negative and -positive cells.
7.5 to 12.5 days postcoitum yielded no CAML/ em- These cells expressed wild-type levels of CAML, as
compared to those in A431, NIH 3T3, HEK 293T, andbryos (actual numbers: 20/, 45/, 0/), indicating an
early lethality. Blastocyst-stage embryos (both CAML/ NRK-49F cell lines (Figure 1C). CAML-negative and
CAML-positive cells have identical appearances (Figureand CAML/) cultured in vitro developed and “hatched”
normally (Hogan et al., 1994), reaching a stage consis- 1D) and proliferate at equivalent rates in the presence
of fetal calf serum (data not shown).tent with in utero developmental day 4.5. CAML/ blas-
tocysts from heterozygous intercrosses grown in vitro
on mouse embryonic fibroblast feeder layers developed
CAML Regulates Long-Term, but Not Short-Term,into embryonic stem (ES) cells with unlimited prolifera-
Effects of EGFR Activationtive capacity and normal morphology and growth pat-
We first assessed the global function of the EGFR interns (data not shown).
these two cell groups by comparing their proliferationSince CAML has been postulated to function in Ca2
induced by EGF in the absence of serum during a 72signaling (Bram and Crabtree, 1994; Holloway and Bram,
hr incubation period with a [3H]thymidine incorporation1996, 1998), we sought to examine whether Ca2 influx
assay during the last 6 hr of the EGF treatment. Deletionwas normal in its absence. However, ES cells do not
of the CAML gene caused a dramatic impairment ofhave a well-characterized Ca2 signal-dependent phe-
EGF-dependent mitogenesis as compared to CAML-notype, making it difficult to test for a role of CAML in
positive cells (Figure 2A). This effect on ligand-depen-these cells. Many previous studies have established that
dent growth appeared to be specific to EGF, since basicthe EGFR, a known Ca2 signaling receptor, is normally
fibroblast growth factor (bFGF)-dependent propagationhighly expressed on epithelial cells (Gusterson et al.,
was the same in both cell types (data not shown).1984). We therefore induced CAML/ ES cells to differ-
We next asked whether failed induction of knownentiate into those with an epithelioid phenotype by
EGFR second messengers (Wells, 1999) was responsi-exposing them to retinoic acid as shown previously (Ho-
ble for the defective receptor function in CAML-negativegan et al., 1983; Figures 1C and 1D). As predicted, the
cells since, as mentioned above, CAML was previouslyresulting cells expressed functional EGFR. To serve as
proposed to promote Ca2 signaling. EGF-dependentcontrols, three independent polyclonal cell pools were
activation of Ca2 influx (Figure 2B) as well as PLC-,prepared by reintroducing a full-length CAML cDNA us-
Shc, and ERK MAPK (Figure 2C) was normal in bothing retrovirus-mediated gene transfer followed by en-
richment of stably transduced cells (Figures 1C and 1D). CAML-negative and CAML-positive cells, however. In
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Figure 2. CAML Regulates the Proliferative
Effect of EGF
(A) CAML-negative cells had impaired mito-
genic responses to EGF. Proliferative indices
were expressed as fold increases in average
incorporated [3H] counts per minute (cpm) in
quadruplicates over those of no treatment.
The cpm for the untreated cells were 103,000
and 73,000 for CAML-negative and -positive
pools, respectively. CAML-positive cells al-
ways had higher cpm than did CAML-nega-
tive cells in the presence of EGF. Both cell
groups responded to EGF by their detectable
increases in cell numbers compared to the
nontreated.
(B) EGF-induced calcium influx was normal
in CAML-negative cells. Averages of 25 cells
treated with EGF (100 ng/ml) at the indicated
time (arrows) were shown.
(C) EGF-induced activation of signaling inter-
mediates was the same in both cell groups.
Immunoprecipitation of lysates from equal
numbers of EGF-treated cells using anti-PLC-
 polyclonal antibodies, anti-Shc monoclonal
antibodies, or anti-ERK2 monoclonal anti-
bodies, followed by immunoblotting using
anti-phosphotyrosine (pTyr) monoclonal anti-
bodies, or ERK2 kinase assay using myosin
basic protein (MBP) as a substrate, respec-
tively. Representatives of four experiments
are shown.
addition, EGF-dependent chemotaxis in a typical 2 hr inactivated and not ubiquitinated are recycled to the cell
surface (Levkowitz et al., 1998; Bao et al., 2000; Seto etmigration assay was similar in both cell types (data not
shown), thus indicating that short-term signaling induced al., 2002). To test for a potential role of CAML in these
pathways, we quantitated surface EGFR in CAML-nega-by the EGFR does not depend upon the CAML protein.
tive cells following exposure to ligand in the absence of
fetal calf serum. CAML-negative cells showed the nor-CAML Is Required for Efficient EGFR Recycling
To determine if the EGF-induced proliferative defect in mal initial EGF-induced downregulation of surface
EGFR, in the same fashion as did CAML-positive cells.CAML-negative cells resulted from lower numbers of
EGFR molecules, we measured total cellular levels of However, the typical rapid reappearance of the receptor
on the cell surface, as previously observed by othersthe receptor at steady state by Western blotting. Surpris-
ingly, lysates of CAML-negative cells had increased (Levkowitz et al., 1998; Bao et al., 2000), was dramati-
cally impaired in cells lacking CAML (Figure 3C). Theamounts of the EGFR, as compared to those from multi-
ple independent CAML-positive cell pools (Figure 3A, rate of surface EGFR reappearance following EGF treat-
ment in CAML-positive cells was analogous to that oftop). This paradox was partially resolved by the finding
that CAML-negative cells had a significantly depressed A431 cells, which recovered near normal surface recep-
tor levels also by 60 min of treatment (Figures 3C andratio of cell surface to total EGFR levels in comparison
to CAML-positive cells, as determined by [125I]EGF bind- 3D), indicating that CAML reintroduction effectively re-
stored the wild-type recycling phenotype to CAML-neg-ing to intact cells (Figure 3A, bottom). In addition, EGFR
mRNA levels were comparable in both CAML-negative ative cells. As an independent verification for the effect
of CAML deficiency on receptor recycling in an alterna-and CAML-positive cells (CAML2) as determined by
Taqman RT-PCR (data not shown). Together, these re- tive system, we tested stable expression of a previously
characterized dominant-negative form of CAML (CAML1-sults raised the possibility that CAML might act by spe-
cifically directing trafficking of the receptor toward the 189) (von Bulow and Bram, 1997) in A431 cells. CAML1-
189 induced qualitatively similar changes in EGFR traf-cell surface.
EGFRs are rapidly internalized once activated (Ceresa ficking (Figures 3B and 3D).
To delineate further the mechanism of the defectiveand Schmid, 2000). The endocytosed receptors then
undergo a sorting process in which the multiply monoubi- response to ligand, we separately measured specific
rates of internalization and recycling of the receptor.quitinated receptors are degraded, while those that are
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Figure 3. CAML Is Required for Efficient
EGFR Recycling
(A and B) Total cellular EGFR levels (top) and
the ratio of relative cell surface to total EGFR
levels (bottom) in the presence of fetal calf
serum in CAML-negative and -positive cell
pools (A) and A431 cells stably expressing a
control GFP or a dominant-negative CAML
(GFP-CAML1-189) (B). Surface EGFR levels
were determined by [125I]EGF binding to intact
cells. The ratios for CAML/ and A431 GFP
CAML1-189 cells were set at 1. Equal loading
was verified by actin immunoblotting.
(C and D) Rates of surface EGFR downregula-
tion in CAML-negative and -positive cells (C)
and A431 cells (D) following exposure to EGF
at time 0. Surface EGFR at the indicated times
were expressed as percentages of the initial
surface level of each cell group.
(E) EGFR internalization in CAML-negative
and -positive cells following EGF treatment at
time 0. Rates of [125I]EGF internalization were
expressed as percentages of the initial sur-
face level of each cell group.
(F) EGFR recycling in CAML-negative and
-positive cells. Rates of reappearance in the
supernatant of internalized intact [125I]EGF
were expressed as percentages of the initial
surface level of each cell group. Representa-
tives of 2–4 experiments are shown.
EGFR-dependent uptake of ligand was identical in cells degradation, instead of retarded recycling, we repeated
the experiment in the presence of either a combinationregardless of the presence of CAML, suggesting that
it is not required for receptor binding and coated pit- of the lysosomotropic inhibitor chloroquine (Cooper et
al., 1988) and the highly specific proteasome inhibitormediated endocytosis (Figure 3E). However, the subse-
quent recycling of internalized receptors was significantly lactacystin (Longva et al., 2002), or monensin, a carbox-
ylic ionophore that exerts diverse intracellular effects,retarded in CAML-negative cells (Figure 3F). It appears,
therefore, that homozygous loss of the CAML locus leads including specific disruption of the recycling routing of
internalized EGFR (Levkowitz et al., 1998; Bao et al.,to a cytoplasmic accumulation of the EGFR and a relative
deficiency in surface expression following receptor activa- 2000). We first verified in these cells that lactacystin
effectively inhibited degradation of the EGFR by West-tion, through effects on the recycling rate.
If the increased cytoplasmic EGFR in CAML-negative ern blotting (data not shown). To confirm the effects of
monensin and chloroquine, we repeated the experimentcells resulted from internalized, trapped receptors rather
than from a synthetic defect, then EGF would be pre- shown in Figure 3F in CAML-positive cells; monensin
effectively blocked the recycling of intact [125I]EGF, whiledicted to be taken up and deposited to a greater extent
in mutant cells. To test this prediction, both cell groups chloroquine significantly reduced the levels of tricholo-
roacetic acid-soluble (degraded) [125I]EGF released fromwere treated with rhodamine-conjugated EGF in a time
course experiment at 37C. We observed comparable cells (data not shown). These agents did not affect the
internalization of EGF, since treated cells exhibited simi-degrees and rates of uptake of the fluorescent ligand
after 10 min of incubation (Figures 4A and 4C), in agree- lar degrees of uptake of rhodamine-conjugated EGF at
10 min as did untreated cells (data not shown). At 30 min,ment with their similar internalization rates (Figure 3E).
However, at later time points, CAML-negative cells chloroquine and lactacystin together caused a slight rise
in the levels of labeled EGF in both cell groups (Figuresshowed a substantially greater cytosolic accumulation
of the labeled ligand than did CAML-positive cells (Fig- 4B and 4D). However, inhibition of recycling by monen-
sin caused a marked increase in accumulation of EGFures 4A and 4C), consistent with delayed recycling in
mutant cells. in CAML-positive cells only, bringing it up to the level
seen in CAML-negative cells (Figures 4B and 4D), indi-To determine whether this accumulation of labeled
ligand in CAML-negative cells was a result of depressed cating that the lack of ligand buildup in CAML-positive
CAML Is Required for EGFR Recycling
249
Figure 4. Rhodamine-Conjugated EGF Ac-
cumulates in CAML-Negative Cells as a Re-
sult of Retarded Recycling
(A) Although rhodamine-conjugated EGF is
internalized at the same rate in CAML-nega-
tive (DAPI blue) and CAML-positive cells
(green and DAPI blue) at 10 min, EGF (red)
accumulates to a greater extent in CAML-
negative cells than in CAML-positive cells at
later time points. Representatives of three ex-
periments are shown.
(B) Rhodamine-conjugated EGF accumulates
in CAML-positive cells in the presence of Mo-
nensin (100 M), a selective recycling inhibi-
tor. Cells were pretreated with the indicated
agents and incubated for 30 min with rhoda-
mine EGF as in (A). Cq, Chloroquine (100 M),
a lysosomal inhibitor; Lc, Lactacystin (50M),
a highly selective proteasome inhibitor.
(C) 100 cells of each cell group in (A) were
counted, and the percentage of rhodamine
EGF-positive cells is plotted.
(D) 100 cells of each cell group in (A) (30 min)
and in (B) were counted, and the percentage
of rhodamine EGF-positive cells is plotted.
RhodEGF, rhodamine-conjugated EGF.
cells is due to their normal recycling activity rather than using EGFR monoclonal antibodies for immunoprecipi-
enhanced degradation. In summary, CAML appears to tation again revealed the presence of a receptor-CAML
regulate the efficient recycling capacity of the EGFR. complex (Figure 5A, bottom). Similar results were ob-
tained from CAML-positive ES cells and the independent
cell line, U87 MG (see below).CAML Interacts with the EGFR
If CAML binds EGFR to mediate recycling, the degreein a Ligand-Dependent Fashion
of interaction between the two proteins might vary asCAML could influence EGFR trafficking through an indi-
a function of ligand treatment. Quantitative immunopre-rect mechanism or might instead directly regulate recy-
cipitation-Western blotting experiments revealed a 3-foldcling via a physical association with the receptor. We
augmentation of CAML-EGFR association at 2 min aftertherefore examined endogenous CAML and EGFR for a
EGFR stimulation, followed by a gradual decline (Figurespotential interaction. A431 cells were used to avoid a
5B and 5C), thus consistent with this suggestion.possible risk of artifact due to exogenous overproduc-
To serve as a control for the specific association be-tion of the proteins. Moreover, A431 cells have been
tween CAML and the EGFR, we asked if CAML inter-used extensively for studies on EGFR functions, and
acted with the FGF receptor 1 (FGFR1), since bFGF-they display normal kinetics of receptor endocytosis
dependent proliferation does not require the presenceand recycling (Teslenko et al., 1987; Sorkin et al., 1991;
of CAML. PC-12 cells were used because they expressMasui et al., 1993). CAML was immunoprecipitated from
the high levels of functional FGFR1 (Foehr et al., 2001;whole-cell lysates using monoclonal antibodies and as-
Hayashi et al., 2001) necessary for critical immunopre-sociated proteins detected by Western blotting. Indeed,
cipitation analysis. There was no evidence of an interac-we found that EGFR specifically interacted with CAML
tion between CAML and the FGFR1 in either untreatedin A431 lysates (Figure 5A, top), while control antibodies
did not precipitate the receptor. The reverse experiment or bFGF-treated cells (Figures 5D and 5E). We obtained
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Figure 5. CAML Binds the EGFR
(A) Immunoprecipitation (IP) of 2 mg of total
lysate proteins from A431 cells using anti-
CAML (top), anti-EGFR (bottom) monoclonal
antibodies, or isotype-matched control anti-
bodies; immunoblotting (IB) was done with
indicated polyclonal antibodies. mIgG, mouse
preimmune immunoglobulin G.
(B) Immunoprecipitation of lysates from equal
numbers of EGF-treated A431 cells using
anti-CAML monoclonal antibodies. Immuno-
blotting was done using anti-EGFR (top) or
anti-CAML (bottom) polyclonal antibodies.
The two far right lanes were run on the same
gel as the others but were exposed for a
shorter time to allow visualization of the indi-
vidual EGFR species. Arrowheads denote
three distinct EGFR species, the most rapidly
migrating of which interacts with CAML. “R”
indicates EGFR at resting state; “A” denotes
the new species formed after activation.
WCL, whole-cell lysate.
(C) Immunoblotting of WCL before and after
CAML immunoprecipitation, which effec-
tively depleted greater than 95% of the pro-
tein, indicating that CAML was quantitatively
recovered in the experiment in (B). Equal
loading was verified by actin immunoblotting.
(D) CAML does not bind the FGFR1 in PC-12
cells. Immunoprecipitation of 2.5 mg of total
cellular proteins from untreated or 100 ng/ml
bFGF-treated cells using the indicated mono-
clononal antibodies. Immunoblotting was done
using anti-FGFR1 monoclonal antibodies (top)
or anti-CAML polyclonal antibodies (bottom).
(E) FGFR1 immunoprocipitation as in (D)
quantitatively depleted greater than 98% of
the FGFR1 from PC-12 WCLs, as reimmuno-
precipitation (re-IP) failed to bring down more
FGFR1.
(F and G) Multiple monobiquitination of EGFR
is not required for CAML binding. Immuno-
precipitation from equal numbers of EGF-treated A431 cells using anti-CAML monoclonal antibodies (F) or anti-EGFR polyclonal antibodies
(G). Immunoblotting was done using anti-ubiquitin (top) or anti-EGFR polyclonal antibodies (bottom). Ub-EGFR, ubiquitinated EGFR; Rab IgG,
rabbit preimmune immunoglobulin G.
(H–J) CAML does not function as an EGFR deubiquitinating enzyme. ([H and I], top panels) MG132, a proteasome inhibitor, effectively inhibited
EGF-induced EGFR degradation. Cells were pretreated with 50 M MG132 or DMSO for 30 min before incubation with 50 ng/ml EGF for
indicated times, and total EGFR mass was determined by immunoblotting with anti-EGFR antibodies. Equal loading was verified by actin
immunoblotting. ([H and I], bottom panels) Immunoprecipitation of the same WCLs from CAML-negative (0.75 mg) and CAML-positive (3 mg)
cells using anti-EGFR polyclonal antibodies. Immunoblots were done using anti-ubiquitin monoclonal antibodies or anti-EGFR polyclonal
antibodies, demonstrating no increase in multiply monoubiquitinated EGFR (arrows) in the absence of CAML. (J) A sequential immunoprecipita-
tion experiment confirmed that this major ubiquitinated species was indeed the EGFR. Lysates from MG132-treated cells incubated with EGF
for 60 min were sequentially immunoprecipitated with the same antibodies as indicated (top). The ratio of the ubiquitin to EGFR signal is
plotted (bottom). Representatives of 2–4 experiments are shown.
similar results in CAML-positive ES cells; CAML associ- (Levkowitz et al., 1998; Bao et al., 2000). The more slowly
moving EGFR species represents tyrosine-hyperphos-ated with the EGFR in a ligand-dependent fashion, while
the FGFR1 failed to coimmunoprecipitate with CAML phorylated (activated) and/or multiply monoubiquiti-
nated receptors targeted for degradation, while those(and vice versa) under identical experimental conditions
(data not shown). with faster migration are neither ubiquitinated nor tyro-
sine-hyperphosphorylated, presumably corresponding
to the inactivated EGFR molecules destined to be recy-Multiple Monoubiquitination of the EGFR
Is Not Required for the CAML-EGFR Interaction cled to the cell surface (Levkowitz et al., 1998; Bao et
al., 2000; Haglund et al., 2003; Mosesson et al., 2003;We next examined the state of CAML-associated EGFR
molecules. Previous studies demonstrated that, follow- Figures 5B and 5G). The formation of these two distinct
receptor classes occurred by 2 min after EGFR activa-ing ligand binding, the single most abundant form of the
EGFR in resting cells gives rise to two distinct receptor tion, indicating that they arose from existing receptors
and not from newly synthesized proteins (Figure 5G).populations discernable by migration on SDS-PAGE
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CAML-associated EGFR species had a faster mobility CAML Binds Directly to the Kinase Domain
of the EGFRthan did the EGFR from untreated lysates and comi-
grated with the faster moving of the two receptor types Previous work has implicated the C-terminal region of
the EGFR (residues 958–1186) in trafficking of the recep-present in cells treated with EGF for 10 min (Figure 5B).
In agreement with observations described by others, tor to lysosomes (Opresko et al., 1995). We therefore
tested a deletion mutant of the receptor (residues 1–958)this CAML-associated, rapidly migrating EGFR did not
appear to be ubiquitinated (Figure 5F) or tyrosine-hyper- lacking such sequences C-terminal to the kinase domain
for ability to bind to CAML following expression in 293Tphosphorylated (data not shown) as detected by immu-
noblotting. However, we cannot rule out a small degree cells. Both full-length EGFR as well as this deletion mu-
tant were specifically coprecipitated from lysates withof monoubiquitination below the detectable limit of the
antibodies used. endogenous CAML using anti-CAML antibodies (Figures
6A and 6B), indicating that the C-terminal region is dis-The finding that CAML interacted with the more rapidly
migrating form of the EGFR and was required for efficient pensable for the interaction. CAML binding to the EGFR,
however, required the kinase domain, since shorterrecycling of internalized receptors raised the possibility
that CAML might function as a deubiquitinating enzyme, mutants (residues 1–689, 1–678, 1–669, or 1–651) did not
coprecipitate, although they were efficiently expressedthus promoting recycling by diverting receptors from
the degradative pathway. To test this hypothesis, the (Figures 6A and 6B; and data not shown). Thus, the CAML-
EGFR interaction requires sequences within or near theextent of EGFR ubiquitination in response to ligand
treatment in both CAML-negative and CAML-positive kinase domain, but not the C-terminal tail of the receptor.
CAML may bind the EGFR directly or through an adap-cells was compared by immunoblotting. Lysates from
both cell types, normalized to contain similar amounts tor protein. To test for a direct interaction, we synthesized
recombinant EGFR mutants in an in vitro E. coli-basedof total EGFR, were immunoprecipitated with EGFR anti-
bodies and probed with ubiquitin antibodies. Since mul- transcription and translation system. These polypep-
tides were mixed with purified GST-CAML fusion proteintiply monoubiquitinated EGFRs normally are rapidly
degraded, the potent proteasome inhibitor MG132 (Yo- in which the GST protein was fused to the N terminus
of the cytoplasmic domain of CAML (residues 1–189).kouchi et al., 1999) was added to allow detection of this
receptor species. If CAML acts as an EGFR deubiquiti- The kinase domain of the EGFR (residues 683–958) spe-
cifically associated with GST-CAML (Figures 6C and 6D),nating enzyme, multiply monoubiquitinated receptors
would be predicted to accumulate to a greater extent consistent with the in vivo results in 293T cells. There
was no interaction with the control protein GST (Figurein cells lacking the CAML gene. However, we did not
observe elevated levels of ubiquitinated EGFR (indi- 6C). A nonoverlapping EGFR fragment comprising the
C-terminal domain of the receptor failed to show associ-cated by arrows) in CAML-negative cells after receptor
stimulation (Figures 5H and 5I). ation with GST-CAML under identical experimental con-
ditions (Figure 6D). These findings indicate that the ki-In the presence of MG132, we noted some slowly
migrating ubiquitinated material near the top of the gel nase domain is necessary and sufficient for a direct
interaction between the two proteins. Moreover, thein both cell groups, which was more pronounced in
CAML-negative cells (Figures 5H and 5I). To determine “YLVI” motif located at the C-terminal end (residues
954–957) of the kinase domain is not required for CAMLwhether this ubiquitinated material represented proteins
coimmunoprecipitated with the EGFR rather than the binding. This highly conserved region has been demon-
strated to function in concert with other domains on thereceptor itself, a sequential immunoprecipitation experi-
ment was performed (Shamu et al., 1999). Cells were receptor such as the C-terminal tail to direct lysosomal
targeting by associating with the trafficking protein Sort-treated with EGF for 60 min in the presence of MG132.
Precipitated immune complexes prepared as in Figures ing Nexin 1 (Kurten et al., 1996; Jones et al., 2002). A
receptor mutant (683–941) containing the core kinase5H and 5I using EGFR-specific antibodies or rabbit IgG
were eluted from the beads by boiling in an 1% SDS domain but lacking this motif associated efficiently with
the GST-CAML (Figure 6D).and 2 mM DTT solution, and the eluates reimmunopre-
cipitated with the same antibodies. This method com-
pletely eliminated the more slowly migrating ubiquiti- Subcellular Localization
nated material detected before the reimmunoprecipitation of the CAML-EGFR Interaction
(Figure 5J). This result verified the absence of increased In order to identify the location of the CAML-EGFR inter-
ubiquitinated EGFR in both untreated and ligand-treated action in vivo, we simultaneously stained both proteins
CAML-negative cells compared to CAML-positive cells with antibodies in cells. U87 MG cells were used be-
(Figure 5J). Indeed, the ratio of ubiquitinated to total EGFR cause they naturally express endogenous levels of both
was approximately 3-fold lower in CAML-negative cells proteins adequate for antibody staining. We first estab-
(Figure 5J). However, taking into account the 3- to 4-fold lished in these cells that CAML interacted with the EGFR
higher level of total cellular EGFR in the absence of CAML through CAML immunoprecipitation of whole-cell ly-
(see Figure 3A), it appears that the absolute amount of sates, in similar fashion to A431 cells (data not shown).
ubiquitinated EGFR is similar in these cell types. Compara- As has been reported previously by others, we found
ble results were obtained using other proteasome inhibi- that the majority of the EGFR was present at the cell
tors (lactacystin or ALLN; data not shown). These findings surface in unstimulated cells, but underwent rapid endo-
indicate that CAML is most likely not an EGFR-deubiquiti- cytosis shortly after ligand binding, accumulating in cy-
tosolic vesicles (Figure 7A). CAML staining displayed anating enzyme.
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Figure 6. CAML Binds Directly to the EGFR
Kinase Domain
(A) (Top) Immunoprecipitation of endogenous
CAML from lysates of 293T cells transiently
expressing EGFR mutants, using anti-CAML
polyclonal antibodies. Immunoblotting was
done with anti-EGFR monoclonal antibodies
specific for an extracellular epitope of the re-
ceptor or anti-CAML monoclonal antibodies.
(Bottom) Immunoblot of the same WCLs to
verify expression of each construct. Equal
loading was confirmed by actin immuno-
blotting.
(B) Diagrams of the EGFR mutants used in
(A) and others (data not shown), and a sum-
mary of their CAML binding properties in vivo.
TM, transmembrane domain; Jx, juxtamem-
brane region.
(C) Recombinant EGFR mutants with an
amino-terminal 6-His tag were synthesized in
vitro using an E. coli lysate. (Top) A GST pull-
down assay demonstrated that purified GST-
CAML interacted specifically with the kinase
domain of the EGFR. Commassie staining of
the same blot showed that both GST and
GST-CAML were efficiently pulled down (data
not shown). (Bottom) An immunoblot with
anti-6-His monoclonal antibodies of the two
recombinant EGFR mutants used in top.
(D) Diagrams of the EGFR mutants used in
(C) and others (data not shown) and a sum-
mary of their GST-CAML binding properties
in vitro. YLVI, a SXN-1 binding motif at posi-
tion 954.
reticular pattern typical of that of an ER-resident protein, cells (Figure 1). With the use of CAML-negative epitheli-
oid cells, we have discovered a novel role for the proteinwhich did not change after EGFR activation (Figure 7A).
Moreover, costaining of cells with known ER markers in the maintenance of efficient long-term (i.e., prolifera-
tive), but not short-term, effects of EGF (Figure 2). Exami-(concanavalin A and antibodies to PTP1B) showed ex-
tensive overlap with the CAML distribution (Figure 7B), nation of EGFR trafficking kinetics suggests that this
may be a result of delayed receptor recycling in CAML-thus consistent with the notion that CAML resides in
the ER. Superimposition of images from cells doubly negative cells (Figures 3 and 4). Recent studies have
established that enhanced recycling of surface recep-stained for endogenous CAML and EGFR demonstrated
tors effectively leads to augmented ligand-induced pro-very little physical overlap in the unstimulated state,
liferation (Levkowitz et al., 1998; Fallon et al., 2000;while at 5 min of EGF treatment, there was a significant
Sarkar et al., 2002) by continuously replenishing surfaceincrease in colocalization of the two proteins within the
receptor levels necessary for prolonged signaling.cell. Because of the extensive degree of CAML presence
CAML-negative cells have significantly depressed sur-on ER structures throughout the cell, it was not possible
face levels and an increased intracellular accumulationto identify precisely a clear site at which colocalization
of the EGFR under both steady-state and poststimula-was limited. Nonetheless, we did not observe CAML
tion conditions as compared to CAML-positive cellsstaining at the cell surface, and we think it likely that both
(Figure 3), thus in line with this notion.proteins interact with each other within the cytoplasm
Upon activation, the EGFR is rapidly internalized andshortly after receptor internalization, in agreement with
later enters a complex sorting process. c-Cbl binds di-the kinetics suggested by the coimmunoprecipitation
rectly to and ubiquitinates internalized receptors, whichexperiments described above.
are subsequently delivered to the lysosome for degrada-
tion (Levkowitz et al., 1998). Alternatively, a significant
Discussion fraction of endocytosed receptors escapes c-Cbl-medi-
ated ubiquitination and becomes dephosphorylated be-
We have explored the in vivo function of CAML through fore being diverted toward the recycling route (Levko-
gene inactivation in the mouse. Although loss of CAML witz et al., 1998; Bao et al., 2000). However, the factors
results in early embryonic lethality, ES cells lacking the that identify and sort this cargo into the recycling endo-
some are currently unclear. The direct physical bindinggene are viable and indistinguishable from wild-type
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Figure 7. Subcellular Localization of the
CAML-EGFR Association
(A) Micrographs of U87 MG cells untreated
or treated with 200 ng/ml EGF for 5 min and
immunostained for endogenous CAML
(green) and EGFR (red) demonstrating their
partial colocalization after EGF treatment
(yellow, arrows).
(B) Micrographs of U87 cells immunostained
for endogenous CAML, endogenous PTP1B
(untreated cells), or endogenous EGFR (cells
treated as in [A]), and the ER marker ConA.
Following EGFR stimulation, the ER distribu-
tions of PTP1B (data not shown) and CAML
(A) did not change noticeably. The magnified
insets are shown in the “Inset” column. Rep-
resentative results from three experiments
are shown.
of CAML to the EGFR in a ligand-dependent fashion These data suggest that CAML may regulate EGFR
recycling not by deubiquitinating the receptor but more(Figures 5 and 6), especially to the more rapidly migrat-
ing species most likely corresponding to the nonubi- likely by influencing trafficking steps downstream of the
ubiquitination machinery. The majority of accumulatedquitinated and tyrosine-hypophosphorylated receptor
(Figure 5), is consistent with its proposed function in EGFR in CAML-negative cells does not appear to be
multiply monoubiquitinated in response to ligand (Fig-receptor recycling. The finding that CAML directly inter-
acts with the core kinase domain of the receptor (Figure ures 5H–5J). We favor the hypothesis, therefore, that it
represents a population of molecules unable to com-6) may also be consistent with its potential role in recy-
cling, since intrinsic receptor kinase activities have been plete the recycling process in the absence of CAML.
Recently, the EGFR was shown to migrate to the ERimplicated in regulating EGFR trafficking, including recy-
cling, but not lysosomal targeting (Honegger et al., 1990; after ligand-induced endocytosis, where it is dephos-
phorylated by the PTP1B, a widely expressed, prototypi-Wiley et al., 1991). Receptor mutants lacking this region
were efficiently degraded in the lysosome in a constitu- cal nontransmembrane PTP that dephosphorylates
several RTKs, including the EGFR. After being dephos-tive fashion and yet failed to undergo other aspects of
normal routing (Opresko et al., 1995). Of late, ESCRT-I phorylated, the receptor can be targeted to the recycling
pathway (Flint et al., 1997; Haj et al., 2002). Experiments(endosomal sorting complex required for transport-1)
was characterized in yeast (Katzmann et al., 2001), employing immunofluorescent staining suggest that
CAML may interact with the EGFR, not at the cell sur-which recognizes and delivers ubiquitinated membrane
proteins to multivesicular bodies, a late endosomal com- face, but within the cytoplasm following internalization
of the receptor (Figure 7A). One possibility is that CAMLpartment intimately linked to the lysosome. Here we
provide evidence suggesting a model in which CAML may bind directly to the EGFR kinase domain to deliver
the receptor to the recycling pathway after it is dephos-may serve an opposite function to ESCRT-I in receptor
trafficking by preferentially binding to nonubiquitinated phorylated by the PTP1B, once all three proteins con-
verge at the ER shortly after receptor endocytosis.receptors to aid in their return to the cell surface.
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Experimental Procedures 2 ng/ml and 10 ng/ml (for ES-derived and A431 cells, respectively)
[125I]EGF (NEN) in cold BB, washed four times, and solubilized with
1 N NaOH, and associated cpm was determined. We also usedGeneration of CAML Knockout Mice and Cells
129/SvJ ES cells (InCyte Genomics) were electroporated with the 8 ng/ml [125I]EGF (for ES-derived cells) and observed similar results.
Nonspecific binding (as cpm not competed away by 400-fold excesstargeting plasmid, and 54 clones were screened by Southern blots
to obtain 10 recombinants. Four recombinants were injected into cold EGF) was subtracted from the total counts. Ratios of surface
to total EGFR levels were expressed as relative surface receptorblastocysts to produce chimeric mice, which were crossed to pro-
duce heterozygotes. CAML/ ES cells from blastocyst-stage em- levels divided by total cellular EGFR determined by densitometry.
bryos produced by heterozygous intercrosses were isolated and
differentiated by treating with 1 M retinoic acid as described (Wu EGFR Downregulation Assay
et al., 2001). CAML expression was restored using a bicistronic The EGFR downregulation assay was performed as described (Bao
retroviral vector (ERV) (Wu et al., 2001) ensuring the expressions of et al., 2000). Briefly, cells were treated with 5 and 50 ng/ml EGF
CAML and GFP, which was used for cell sorting. (for ES-derived and A431 cells, respectively) for indicated times,
washed, and acid-stripped. Surface EGFR levels were then deter-
Immunoprecipitation and Western Blotting mined as detailed above.
Cells were lysed on ice (1% Triton X-100, 20 mM HEPES [pH 7.4],
5 mM NaCl, 5 mM MgCl2, 1 mM EGTA, 1 mM EDTA, 1 mM Iodoacet-
EGFR Recycling Assayamide, 100 M Na2VO4, 1 mM PMSF, 10 g/ml leupeptin, 45 g/ml
The EGFR recycling assay was performed as described (Bao et al.,aprotinin). 2–3 mg of lysates was precipitated with 10 g of antigen-
2000). Briefly, cells were incubated with 1 ng/ml [125I]EGF on ice forspecific antibodies or appropriate control antibodies (Pharmingen).
1.5 hr, allowed to internalize for 10 min at 37C, and stopped onProtein samples were resolved on 12% PAGE (CAML, Shc, MBP)
ice. The remaining bound, labeled ligand was acid-stripped off theor 7.5% PAGE (EGFR, PLC-, FGFR1). Membranes were blotted for
cell surface. Cells were transferred back to 37C for indicated timesCAML, EGFR (Santa Cruz), pTyr (UBI), Shc (UBI), ubiquitin (Chemi-
to allow cells to recycle internalized [125I]EGF in the presence of 100-con and Santa Cruz), FGFR1 (UBI), or actin (Sigma).
fold excess unlabeled EGF. Recycled intact [125I]EGF was isolated
from degraded ligand using 3% trichloroacetic acid and 0.3% phos-[3H]Thymidine Incorporation Assay for EGF Response
photungstic acid. Cpm from both intact and degraded ligands wasThe [3H]thymidine incorporation assay for EGF response was per-
determined using a  counter.formed as previously described (Ho et al., 1987). Briefly, 1  104
cells/well were seeded onto a 96-well plate in quadruplicates with
indicated concentrations of EGF or bFGF (Sigma) for 72 hr in binding EGFR Recycling and Internalization Assays
buffer (BB; 20 mM HEPES [pH 7.4], 1% BSA in DMEM) in the absence EGFR recycling and internalization assays were performed as de-
of fetal calf serum. Growth factors were replenished every 24 hr. scribed (Bao et al., 2000). We used 5 ng/ml [125I]EGF for this assay.
1 Ci of [3H]thymidine (Amersham) per well was added 6 hr before For the fluorescence study, cells were untreated or pretreated with
harvesting onto a filter membrane, and incorporated counts were 100 M chloroquine, 100 M monensin (Sigma) for 30 min or 50 M
determined. lactacystin (Calbiochem) for 1 hr before the addition of 0.5 g/ml
rhodamine-conjugated EGF (Molecular Probes) in the presence of
Calcium Influx Assay the same drugs at 37C. At indicated times, cells were washed,
Cells were loaded with fura-2 and analyzed by microfluorometry in acid-stripped, fixed, and stained for CAML as detailed above.
HBSS at 22C using an Attofluor ratiovision system, as described
previously (Holloway and Bram, 1996).
Transient Expression of EGFR Mutants in 293T Cells
Superfect reagents (Qiagen) were used per the manufacturer’s in-
Chemotaxis Assay structions. Briefly, cells on a 10 cm plate were transfected with 10
The chemotaxis assay was performed as previously described (Ra-
g of plasmid DNA, incubated for 48 hr, and lysed on ice. Endoge-
binovitz et al., 1999) with 0.1 and 10 ng/ml EGF. nous CAML was then precipitated from the lysates as detailed
above.
Assay for EGF-Induced ERK MAPK Activity
The assay for EGF-induced ERK MAPK activity was performed as
Production of GST-CAML and Recombinant EGFR,previously described (Karnitz et al., 1995).
and the GST Pull-Down Assay
GST-CAML and GST were produced in E. coli using the pGEX-AT-2Immunofluorescence Staining
vector (Amersham) with the GST protein fused to the N-terminalCells were fixed and permeablized with either 50% methanol/50%
domain of CAML (residues 1–189), followed by affinity purificationacetone for 2 min at 20C (for U87 cells) or 4% paraformaldehyde
with GSH agarose. Recombinant proteins containing the indicatedfor 15 min followed by 0.2% Triton X-100 for 2 min at room tempera-
domains of the EGFR were synthesized in vitro using an E. coliture (for ES-derived cells). Endogenous CAML was stained using
lysate (RTS-100, Roche) following the manufacturer’s directions.anti-CAML rabbit polyclonal antibodies (875 ng/ml for U87 cells and
Templates were generated by PCR using primers that directed addi-300 ng/ml for ES-derived cells), followed by biotinylated goat anti-
tion of a C-terminal 6-His tag for purification on Ni-NTA agarose andrabbit IgG antibodies (1:1000; Vector) and fluorescein-conjugated
detection by Western blotting. Binding reactions were performed inAvidin DCS (1:1000) or Texas Red-conjugated Avidin DCS (1:1000;
40 l of 20 mM HEPES (pH 7.4), 50 mM NaCl, 5 mM MgCl2, 1 mMVector Laboratories). Endogenous EGFR and PTP1B were detected
PMSF at 4C for 1 hr after addition of 3 g of either GST-CAML orusing anti-EGFR mouse monoclonal antibodies (4 g/ml, Santa
GST alone. Reactions were adsorbed to glutathione agarose,Cruz) and anti-PTP1B monoclonal antibodies (2g/ml; Transduction
washed extensively with the same buffer, and analyzed by WesternLaboratories), respectively, followed by Texas red-conjugated don-
blotting with anti-6-His monoclonal antibody.key anti-mouse IgG antibodies (15 g/ml; Jackson Immunore-
search). Fluorescein-conjugated ConA (1 g/ml; Sigma) was used
to stain ER structures. For ES-derived cells, nuclear counterstaining Acknowledgments
was done using DAPI (300 nM; Molecular Probes). The GFP used in
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